Published in Virology on October 01, 1970
Proteins of vesicular stomatitis virus and of phenotypically mixed vesicular stomatitis virus-simian virus 5 virions. J Virol (1971) 4.02
Isolation and purification of the envelope proteins of Newcastle disease virus. J Virol (1973) 3.49
Glycolipid content of vesicular stomatitis virus grown in baby hamster kidney cells. J Virol (1971) 2.68
Proteins and glycoproteins of paramyxoviruses: a comparison of simian virus 5, Newcastle disease virus, and Sendai virus. J Virol (1971) 2.44
Carbohydrate composition of vesicular stomatitis virus. J Virol (1971) 2.40
Polypeptide synthesis in simian virus 5-infected cells. J Virol (1977) 2.20
Identification of measles virus-specific hemolysis-inihibiting antibodies separate from hemagglutination-inhibiting antibodies. Infect Immun (1975) 2.01
Inhibition of glycosylation of the influenza virus hemagglutinin. J Virol (1974) 1.81
Intracellular forms of adenovirus deoxyribonucleic acid. I. Evidence for a deoxyribonucleic acid-protein complex in baby hamster kidney cells infected with adenovirus type 12. J Virol (1972) 1.68
Spin-labeled electron spin resonance study of the lipid-containing membrane of influenza virus. Proc Natl Acad Sci U S A (1971) 1.57
Hemagglutination-inhibition: rapid assay for neuraminic acid-containing viruses. J Virol (1974) 1.42
Carbohydrates of influenza virus. I. Glycopeptides derived from viral glycoproteins after labeling with radioactive sugars. J Virol (1977) 1.33
Sulfated components of enveloped viruses. J Virol (1975) 1.21
Effect of impaired glycosylation on the biosynthesis of Semliki forest virus glycoproteins. J Virol (1975) 1.13
Formation of influenza virus proteins. J Virol (1973) 1.13
Influenza virus proteins: identity, synthesis, and modification analyzed by two-dimensional gel electrophoresis. Proc Natl Acad Sci U S A (1978) 1.08
Fluorosugars inhibit biological properties of different enveloped viruses. J Virol (1976) 1.06
Inhibition of the multiplication of vesicular stomatitis and Newcastle disease virus by 2-deoxy-d-glucose. J Virol (1974) 1.05
Isolation and properties of an RNA polymerase from influenza virus-infected cells. J Virol (1973) 1.04
Biological consequences of neuraminidase deficiency in Newcastle disease virus. J Virol (1983) 0.90
N-linked glycan at residue 523 of human parainfluenza virus type 3 hemagglutinin-neuraminidase masks a second receptor-binding site. J Virol (2010) 0.88
Sialylatin of glycoproteins of murine mammary tumor virus, murine leukemia virus, and Mason-Pfizer monkey virus. J Virol (1976) 0.82
Cell mitotic cycle synthesis of NIL hamster glycolipids including the Forssman antigen. J Cell Biol (1974) 0.80
Outer membrane of avian myeloblastosis virus. J Virol (1973) 0.78
Activation of influenza A viruses by trypsin treatment. Virology (1975) 8.07
Enhancement of the infectivity of influenza A and B viruses by proteolytic cleavage of the hemagglutinin polypeptide. Virology (1975) 6.90
Sequences of mRNAs derived from genome RNA segment 7 of influenza virus: colinear and interrupted mRNAs code for overlapping proteins. Proc Natl Acad Sci U S A (1981) 5.57
The Ebola virus VP35 protein functions as a type I IFN antagonist. Proc Natl Acad Sci U S A (2000) 5.46
GP mRNA of Ebola virus is edited by the Ebola virus polymerase and by T7 and vaccinia virus polymerases. Virology (1995) 5.34
Influenza virus hemagglutinin with multibasic cleavage site is activated by furin, a subtilisin-like endoprotease. EMBO J (1992) 5.05
Proteolytic cleavage of the viral glycoproteins and its significance for the virulence of Newcastle disease virus. Virology (1976) 4.85
The role of viral glycoproteins in adsorption, penetration, and pathogenicity of viruses. Rev Infect Dis (1980) 4.61
Replication of influenza virus in a continuous cell line: high yield of infective virus from cells inoculated at high multiplicity. Virology (1969) 4.45
Two disulfide-linked polypeptide chains constitute the active F protein of paramyxoviruses. Virology (1977) 4.33
Processing of the Ebola virus glycoprotein by the proprotein convertase furin. Proc Natl Acad Sci U S A (1998) 4.33
Comparison of the transcription and replication strategies of marburg virus and Ebola virus by using artificial replication systems. J Virol (1999) 4.32
The gene structure and replication of influenza virus. Annu Rev Biochem (1983) 4.30
Evidence for a ninth influenza viral polypeptide. Virology (1978) 4.21
Inhibition of furin-mediated cleavage activation of HIV-1 glycoprotein gp160. Nature (1992) 4.16
Isolation of paramyxovirus glycoproteins. Association of both hemagglutinating and neuraminidase activities with the larger SV5 glycoprotein. Virology (1972) 4.05
An electron microscopic study of moderate and virulent virus-cell interactions of the parainfluenza virus SV5. Virology (1966) 4.03
Proteins of vesicular stomatitis virus and of phenotypically mixed vesicular stomatitis virus-simian virus 5 virions. J Virol (1971) 4.02
Influenza virus structural and nonstructural proteins in infected cells and their plasma membranes. Virology (1971) 3.96
Inhibition of uncoating of poliovirus by arildone, a new antiviral drug. Virology (1979) 3.80
On the role of the response of the cell membrane in determining virus virulence. Contrasting effects of the parainfluenza virus SV5 in two cell types. J Exp Med (1966) 3.71
Influenza virus proteins. I. Analysis of polypeptides of the virion and identification of spike glycoproteins. Virology (1970) 3.58
Specific inhibition of paramyxovirus and myxovirus replication by oligopeptides with amino acid sequences similar to those at the N-termini of the F1 or HA2 viral polypeptides. Virology (1980) 3.53
Isolation and purification of the envelope proteins of Newcastle disease virus. J Virol (1973) 3.49
The role of cytoplasmic membranes in poliovirus biosynthesis. Virology (1970) 3.46
The Lassa virus glycoprotein precursor GP-C is proteolytically processed by subtilase SKI-1/S1P. Proc Natl Acad Sci U S A (2001) 3.43
Importance of antibodies to the fusion glycoprotein of paramyxoviruses in the prevention of spread of infection. J Exp Med (1980) 3.32
The synthesis of sendai virus polypeptides in infected cells. Virology (1976) 3.26
The structure of the hemagglutinin, a determinant for the pathogenicity of influenza viruses. Virology (1979) 3.25
Synthesis of influenza virus proteins in infected cells: translation of viral polypeptides, including three P polypeptides, from RNA produced by primary transcription. Virology (1976) 3.13
A previously unrecognized influenza B virus glycoprotein from a bicistronic mRNA that also encodes the viral neuraminidase. Proc Natl Acad Sci U S A (1983) 3.08
Recovery of infectious Ebola virus from complementary DNA: RNA editing of the GP gene and viral cytotoxicity. Science (2001) 3.08
Presence of murine leukemia virus envelope proteins gp70 and p15(E) in a common polyprotein of infected cells. J Virol (1976) 2.91
Inhibition of glycoprotein biosynthesis of influenza virus by D-glucosamine and 2-deoxy-D-glucose. Virology (1972) 2.84
Two independent targeting signals in the cytoplasmic domain determine trans-Golgi network localization and endosomal trafficking of the proprotein convertase furin. EMBO J (1995) 2.76
Influenza viruses cause hemolysis and fusion of cells. Virology (1981) 2.73
Glycosphingolipids of plasma membranes of cultured cells and an enveloped virus (SV5) grown in these cells. Proc Natl Acad Sci U S A (1970) 2.73
Glycolipid content of vesicular stomatitis virus grown in baby hamster kidney cells. J Virol (1971) 2.68
Mapping of the two overlapping genes for polypeptides NS1 and NS2 on RNA segment 8 of influenza virus genome. Proc Natl Acad Sci U S A (1980) 2.60
Segment 8 of the influenza virus genome is unique in coding for two polypeptides. Proc Natl Acad Sci U S A (1979) 2.58
Nucleocapsid protein subunits of simian virus 5, Newcastle disease virus, and Sendai virus. J Virol (1970) 2.58
On the role of microtubules in movement and alignment of nuclei in virus-induced syncytia. J Cell Biol (1968) 2.53
The proteins of the parainfluenza virus SV5. 1. Separation of virion polypeptides by polyacrylamide gel electrophoresis. Virology (1969) 2.50
Characterization of filoviruses based on differences in structure and antigenicity of the virion glycoprotein. Virology (1994) 2.48
The synthesis of Sendai virus polypeptides in infected cells. III. Phosphorylation of polypeptides. Virology (1977) 2.48
Lipids of plasma membranes of monkey and hamster kidney cells and of parainfluenza virions grown in these cells. Virology (1969) 2.48
Isolation and properties of the helical nucleocapsid of the parainfluenza virus SV5. Proc Natl Acad Sci U S A (1967) 2.46
Molecular biology and evolution of filoviruses. Arch Virol Suppl (1993) 2.45
Proteins and glycoproteins of paramyxoviruses: a comparison of simian virus 5, Newcastle disease virus, and Sendai virus. J Virol (1971) 2.44
Interactions of Marburg virus nucleocapsid proteins. Virology (1998) 2.37
Measles and subacute sclerosing panencephalitis virus proteins: lack of antibodies to the M protein in patients with subacute sclerosing panencephalitis. Proc Natl Acad Sci U S A (1979) 2.33
Action of guanidine on the replication of poliovirus RNA. Virology (1968) 2.31
Marburg virus, a filovirus: messenger RNAs, gene order, and regulatory elements of the replication cycle. Virus Res (1992) 2.29
Identification of a second protein (M2) encoded by RNA segment 7 of influenza virus. Virology (1981) 2.26
Filovirus-induced endothelial leakage triggered by infected monocytes/macrophages. J Virol (1996) 2.26
How to overcome resistance of influenza A viruses against adamantane derivatives. Antiviral Res (1998) 2.25
Pause on avian flu transmission research. Science (2012) 2.24
Membranous structures associated with translation and transcription of poliovirus RNA. Science (1969) 2.21
Molecular characterization of guinea pig-adapted variants of Ebola virus. Virology (2000) 2.21
Polypeptide synthesis in simian virus 5-infected cells. J Virol (1977) 2.20
Reconstitution of membranes with individual paramyxovirus glycoproteins and phospholipid in cholate solution. Virology (1979) 2.20
Rescue of vector-expressed fowl plague virus hemagglutinin in biologically active form by acidotropic agents and coexpressed M2 protein. J Virol (1994) 2.17
Determination by peptide mapping of the unique polypeptides in Sendai virions and infected cells. Virology (1978) 2.17
A comparison of the polypeptides of four measles virus strains. Virology (1977) 2.15
Proteolytic activation of the influenza virus hemagglutinin: The structure of the cleavage site and the enzymes involved in cleavage. Virology (1981) 2.13
Glycosylation and oligomerization of the spike protein of Marburg virus. Virology (1991) 2.11
Effect of arildone on modifications of poliovirus in vitro. Virology (1980) 2.10
Interdependence of hemagglutinin glycosylation and neuraminidase as regulators of influenza virus growth: a study by reverse genetics. J Virol (2000) 2.09
Regulation of receptor binding affinity of influenza virus hemagglutinin by its carbohydrate moiety. J Virol (1997) 2.09
Crystal structure of the matrix protein VP40 from Ebola virus. EMBO J (2000) 2.08
Processing of viral glycoproteins by the subtilisin-like endoprotease furin and its inhibition by specific peptidylchloroalkylketones. Biochimie (1994) 2.07
Activation of the Sendai virus fusion protein (f) involves a conformational change with exposure of a new hydrophobic region. J Biol Chem (1981) 2.04
Proteolytic cleavage by plasmin of the HA polypeptide of influenza virus: host cell activation of serum plasminogen. Virology (1973) 2.01
Association of influenza virus proteins with cytoplasmic fractions. Virology (1974) 2.00
Oligopeptides that specifically inhibit membrane fusion by paramyxoviruses: studies on the site of action. Virology (1983) 2.00
Activation of precursors to both glycoporteins of Newcastle disease virus by proteolytic cleavage. Virology (1977) 2.00
Cell-fusing activity of visna virus particles. Virology (1967) 1.98
Studies on the adaptation of influenza viruses to MDCK cells. EMBO J (1984) 1.98
Expression of the influenza virus haemagglutinin in insect cells by a baculovirus vector. EMBO J (1986) 1.98
The function of the neuraminidase in membrane fusion induced by myxoviruses. Virology (1980) 1.97
Action of dichlorobenzimidazole riboside on RNA synthesis in L-929 and HeLa cells. J Cell Biol (1976) 1.96
Role of Staphylococcus protease in the development of influenza pneumonia. Nature (1987) 1.96
Characterization of poliovirus-specific structures associated with cytoplasmic membranes. Virology (1970) 1.95
Protease activation mutants of sendai virus. Activation of biological properties by specific proteases. Virology (1976) 1.95
Immunological studies of the functions of paramyxovirus glycoproteins. Virology (1981) 1.93
Influenza C virus uses 9-O-acetyl-N-acetylneuraminic acid as a high affinity receptor determinant for attachment to cells. J Biol Chem (1986) 1.92
Infection and activation of monocytes by Marburg and Ebola viruses. J Virol (2001) 1.90